Xcout Intel
Capstan Medical
Capstan Medical is a medical-device company developing minimally invasive, catheter-based systems for transcatheter mitral valve replacement. Its technology is intended for patients with mitral valve disease and the clinicians who treat them, particularly those who may be at elevated risk for open-heart surgery.
Subscribe to see Capstan Medical’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Capstan Medical at a glance
Capstan Medical is a medical devices company headquartered in United States. Xcout tracks 10 named people at Capstan Medical, including Maggie Nixon (CEO). Xcout recorded 27 job postings from Capstan Medical in the last 90 days.
Capstan Medical leadership
- Maggie NixonCEO
- Dan WallaceFounder
- Brian KingHead of Finance
- David TungHead of Operations and Quality
- Evelyn HaynesHead of Delivery Systems and Accessories
- Greg DachsHead of R&D
4 more named people on record for Capstan Medical, with roles, board committees and tenure — see the full roster →
Hiring at Capstan Medical
Xcout recorded 27 job postings from Capstan Medical in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Capstan Medical's hiring signals →
Tech stack
Capstan Medical competitors
A few of Capstan Medical's closest competitors — see the full list of competitors and alternatives →
Micro Interventional Devices, Inc. is a medical equipment manufacturing company developing novel solutions for structural heart disease treatments like mitral valve repair.
HighLife Medical is a pre-commercial stage medical device company headquartered in Paris, France, with additional facilities in Irvine, California. The company develops trans-septal mitral valve replacement (TSMVR) technologies for treating structural heart disease.
CroiValve is a Dublin-based medical technology company focused on developing minimally invasive heart valve devices, such as the DUO System, to treat tricuspid regurgitation.
Laguna Tech USA, Inc. is a medical technology company that develops structural heart solutions, specifically focusing on transcatheter aortic valve systems. The company's flagship product, the ZETA Transcatheter Aortic Valve System, is an investigational device designed to treat both aortic regurgitation and aortic stenosis.
Coramaze Technologies is a clinical and pre-commercial stage medical device company founded in 2013, with offices in Germany and Israel. The company is focused on developing an innovative transcatheter tricuspid valve repair system called TriPair.
Neovasc is a medical-device company that developed cardiovascular products, notably the Neovasc Reducer system for patients with refractory angina who are not adequately helped by conventional treatments. It also developed the Tiara transcatheter mitral valve replacement system for people with mitral valve disease; Neovasc was acquired by Shockwave Medical in 2023.
Get Capstan Medical's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Capstan Medical in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access